Antidepressant prescription pattern in a hospice program

Paulo R. Shiroma, Yonas Endale Geda, Amit Mohan, Jarrett Richardson

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Prevalence of treatable depression is as high as 25% among terminally ill patients. The incidence of antidepressant use was ascertained at the Mayo Hospice Program in Rochester, Minnesota, from June 1, 2007, to December 31, 2008. The 18-month cumulative probability to receive an antidepressant during hospice was estimated at 11.7%. Depression and selective serotonin reuptake inhibitors (SSRIs) were the most common clinical indication and class of antidepressant, respectively. Survival was the main predictor to receive an antidepressant with an odds ratio of 2.71 (95%CI: 1.60-4.60) for each additional day in hospice. Proper diagnostic tools for this population, education about the benefits of antidepressants in palliative care, and clear guidelines about antidepressant class and dosages are needed.

Original languageEnglish (US)
Pages (from-to)193-197
Number of pages5
JournalAmerican Journal of Hospice and Palliative Medicine
Volume28
Issue number3
DOIs
StatePublished - May 2011

Fingerprint

Hospice Care
Antidepressive Agents
Prescriptions
Hospices
Terminally Ill
Serotonin Uptake Inhibitors
Palliative Care
Odds Ratio
Guidelines
Education
Survival
Incidence
Population

Keywords

  • antidepressive agents
  • hospice
  • incidence
  • palliative care
  • psychotropics
  • terminally ill

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Antidepressant prescription pattern in a hospice program. / Shiroma, Paulo R.; Geda, Yonas Endale; Mohan, Amit; Richardson, Jarrett.

In: American Journal of Hospice and Palliative Medicine, Vol. 28, No. 3, 05.2011, p. 193-197.

Research output: Contribution to journalArticle

Shiroma, Paulo R. ; Geda, Yonas Endale ; Mohan, Amit ; Richardson, Jarrett. / Antidepressant prescription pattern in a hospice program. In: American Journal of Hospice and Palliative Medicine. 2011 ; Vol. 28, No. 3. pp. 193-197.
@article{6407f33af83b4b7e990a503277ba3c69,
title = "Antidepressant prescription pattern in a hospice program",
abstract = "Prevalence of treatable depression is as high as 25{\%} among terminally ill patients. The incidence of antidepressant use was ascertained at the Mayo Hospice Program in Rochester, Minnesota, from June 1, 2007, to December 31, 2008. The 18-month cumulative probability to receive an antidepressant during hospice was estimated at 11.7{\%}. Depression and selective serotonin reuptake inhibitors (SSRIs) were the most common clinical indication and class of antidepressant, respectively. Survival was the main predictor to receive an antidepressant with an odds ratio of 2.71 (95{\%}CI: 1.60-4.60) for each additional day in hospice. Proper diagnostic tools for this population, education about the benefits of antidepressants in palliative care, and clear guidelines about antidepressant class and dosages are needed.",
keywords = "antidepressive agents, hospice, incidence, palliative care, psychotropics, terminally ill",
author = "Shiroma, {Paulo R.} and Geda, {Yonas Endale} and Amit Mohan and Jarrett Richardson",
year = "2011",
month = "5",
doi = "10.1177/1049909110385539",
language = "English (US)",
volume = "28",
pages = "193--197",
journal = "American Journal of Hospice and Palliative Medicine",
issn = "1049-9091",
publisher = "SAGE Publications Inc.",
number = "3",

}

TY - JOUR

T1 - Antidepressant prescription pattern in a hospice program

AU - Shiroma, Paulo R.

AU - Geda, Yonas Endale

AU - Mohan, Amit

AU - Richardson, Jarrett

PY - 2011/5

Y1 - 2011/5

N2 - Prevalence of treatable depression is as high as 25% among terminally ill patients. The incidence of antidepressant use was ascertained at the Mayo Hospice Program in Rochester, Minnesota, from June 1, 2007, to December 31, 2008. The 18-month cumulative probability to receive an antidepressant during hospice was estimated at 11.7%. Depression and selective serotonin reuptake inhibitors (SSRIs) were the most common clinical indication and class of antidepressant, respectively. Survival was the main predictor to receive an antidepressant with an odds ratio of 2.71 (95%CI: 1.60-4.60) for each additional day in hospice. Proper diagnostic tools for this population, education about the benefits of antidepressants in palliative care, and clear guidelines about antidepressant class and dosages are needed.

AB - Prevalence of treatable depression is as high as 25% among terminally ill patients. The incidence of antidepressant use was ascertained at the Mayo Hospice Program in Rochester, Minnesota, from June 1, 2007, to December 31, 2008. The 18-month cumulative probability to receive an antidepressant during hospice was estimated at 11.7%. Depression and selective serotonin reuptake inhibitors (SSRIs) were the most common clinical indication and class of antidepressant, respectively. Survival was the main predictor to receive an antidepressant with an odds ratio of 2.71 (95%CI: 1.60-4.60) for each additional day in hospice. Proper diagnostic tools for this population, education about the benefits of antidepressants in palliative care, and clear guidelines about antidepressant class and dosages are needed.

KW - antidepressive agents

KW - hospice

KW - incidence

KW - palliative care

KW - psychotropics

KW - terminally ill

UR - http://www.scopus.com/inward/record.url?scp=79955530920&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955530920&partnerID=8YFLogxK

U2 - 10.1177/1049909110385539

DO - 10.1177/1049909110385539

M3 - Article

C2 - 21051782

AN - SCOPUS:79955530920

VL - 28

SP - 193

EP - 197

JO - American Journal of Hospice and Palliative Medicine

JF - American Journal of Hospice and Palliative Medicine

SN - 1049-9091

IS - 3

ER -